Aug 20, 2026
Moderna and Merck say Phase 3 trial results suggest their individualized mRNA vaccine can prevent melanoma from recurring or spreading in patients who have had the disease.
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service